R. Cherubini

Regional node failure in patients with four or more positive lymph nodes submitted to conservative surgery followed by radiotherapy to the breast.

M. Colozza, C. Aristei, F. Chionne, 2000, American journal of clinical oncology.

Capecitabine in association with epirubicin and docetaxel as a first line treatment in advanced breast cancer a multicenter phase II study

O. Garrone, R. Rosso, M. Venturini, 2001 .

Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients

M. Tonato, V. Ludovini, M. Colozza, 2003, Breast Cancer Research and Treatment.

HER2 overexpression as a predictive marker in a randomized trial comparing adjuvant cyclophosphamide/methotrexate/5-fluorouracil with epirubicin in patients with stage I/II breast cancer: long-term results.

M. Tonato, M. Colozza, S. Gori, 2005, Clinical breast cancer.

Results of a Prospective Study with High-dose Etoposide, Thiotepa and Carboplatin and Peripheral Blood Stem Cell Rescue for High-risk Stage II-IIIA and Selected Stage IV Breast Cancer Patients

M. Tonato, M. Martelli, A. Tabilio, 2001, Tumori.

Weekly Paclitaxel in Metastatic Breast Cancer Patients: A Phase II Study

M. Tonato, M. Colozza, S. Gori, 2002, Tumori.

Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer

L. Crinò, M. Tonato, M. Colozza, 2004, British Journal of Cancer.